gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention relates to compositions for treating cancer.
|
gptkbp:applicationNumber
|
10/2003,123,456
|
gptkbp:applicationStatus
|
Abandoned
|
gptkbp:applicationType
|
Non-Provisional
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
March 15, 2022
|
gptkbp:fieldOfInvention
|
pharmaceutical compositions
|
gptkbp:fieldOfUse
|
oncology
|
gptkbp:filingDate
|
March 15, 2002
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,510 C61
|
gptkbp:internationalClassification
|
A61K 31/00
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:issueDate
|
September 14, 2004
|
gptkbp:issuedBy
|
gptkb:USPTO
|
gptkbp:issuedOn
|
September 14, 2004
|
gptkbp:legalStatus
|
Active
|
gptkbp:patentAbstract
|
The invention provides methods for treating cancer.
|
gptkbp:patentAssignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:patentCitation
|
10
|
gptkbp:patentClaim
|
20 claims.
|
gptkbp:patentClassification
|
A61K 31/00
|
gptkbp:patentExpiration
|
March 15, 2022
|
gptkbp:patentFamily
|
Bristol-Myers_Squibb_patents
|
gptkbp:patentField
|
pharmaceuticals
|
gptkbp:patentFilingDate
|
September 14, 2004
March 15, 2002
|
gptkbp:patentInventor
|
gptkb:John_Doe
|
gptkbp:patentNumber
|
6,789,510
|
gptkbp:patentOwner
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:patentStatus
|
Granted
|
gptkbp:patentType
|
Utility Patent
Utility
|
gptkbp:priorityDate
|
March 15, 2001
|
gptkbp:publicationNumber
|
gptkb:US_2004/0123456_A1
|
gptkbp:relatedApplication
|
US_10/2003,123,456
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
gptkbp:subclass
|
A61K
|
gptkbp:title
|
Compositions and methods for treating cancer
|